has_role organic heterocyclic compound insulin-sensitizing drug pioglitazone 0 356.11946 356.447 pubmed:34009030 (+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione C19H20N2O3S lincs.smallmolecule:LSM-1592 HYAFETHFCAUJAY-UHFFFAOYSA-N pubmed:20797618 NCIt:C71633 hmdb:HMDB0015264 kegg.drug:D08378 CHEBI:8228 pubmed:27842070 pubmed:34006325 wikipedia.en:Pioglitazone SNOMEDCT:395828009 chemspider:4663 chebi_ontology kegg.compound:C07675 pubmed:12879407 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione reaxys:3595485 pubmed:33995271 pubmed:33983968 pioglitazone pioglitazonum A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity. CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1 pubmed:33864097 pubmed:33798599 drugbank:DB01132 pubmed:14522601 Pioglitazone patent:US4687777 InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23) drugcentral:2179 MESH:C060836 pubmed:18215232 patent:EP193256 SNOMEDCT:326058001 pubmed:17628757 pioglitazona cas:111025-46-8